Capita Suggests to BUY this Pharma Major for Better Gains

BUY            : IPCA Laboratories at Rs 426
BSE Code   : 524494
NSE Symbol: IPCALAB
Market Lot  : 1

Ipca Laboratories is a backward integrated, fast growing pharmaceutical  
major, with a strong thrust on exports. It has reported 25% jump in net 
sales and a whopping 102% rise in net profit in September 2006 quarter. 
As the sales growth for the second half is expected to continue over  
25% with much better profit margins, the company's financials are set for 
a major uptrend.


Actual EPS for March 2005	:  Rs 31.4
Actual EPS for March  2006	:  Rs 25.6
Projected EPS for March 2007:  Rs  38.1